Estithmar Holding Explores IPO for Healthcare Arm Apex Health

Estithmar Holding QPSC has appointed Rothschild & Co. To serve as an advisor for the potential listing of its healthcare subsidiary, Apex Health, in Doha. This appointment signals a significant strategic move for the Qatari conglomerate as it explores a public offering for its medical arm, a decision that could reshape its financial structure and market presence. Apex Health, a significant and expanding player in the region's healthcare sector, currently manages and operates a substantial network of 2,700 beds across four distinct countries: Qatar, Iraq, Algeria, and Libya. This extensive operational footprint shows its importance and potential value in the healthcare market.

Market Context and Performance

A successful listing of Apex Health would provide a much-needed boost to Qatar's equity capital markets. The market has experienced a relatively quiet period in terms of new listings, with only approximately $375 million raised through just two initial public offerings since 2020. This potential IPO comes at a time when Doha's benchmark index has fallen over 5% since the start of the regional conflict, reflecting broader market anxieties. Despite the broader market downturn and regional instability, Estithmar Holding QPSC has emerged as one of the Gulf's top-performing stocks, with its shares rising about 30% since the conflict began. This resilience notes investor confidence in the company's strategic direction and its diverse portfolio. The Qatar Exchange previously hosted a record $552 million follow-on offering last year, an event where the Abu Dhabi Investment Authority reduced its stake in Qatar's largest telecom operator, demonstrating the market's capacity for large-scale transactions.

Regional IPO Activity

Beyond Estithmar Holding's plans, other significant developments are underway in the Qatari capital markets. State-backed Gulf International Services QSC has announced plans to list its units Al Koot Insurance and Reinsurance and Amwaj Catering Services on the local exchange. These planned listings underline a broader trend of increased activity and diversification within the region's capital markets, as companies seek to unlock value and attract new investment. This surge in activity is indicative of a growing maturity and ambition within the Gulf's financial ecosystem.

In a separate but related development, Qatar’s $580 billion sovereign wealth fund, the Qatar Investment Authority, committed $500 million to General Atlantic’s growth equity strategies. This substantial investment notes the sovereign fund's continued engagement in global growth sectors, even as local markets see new listings and increased domestic capital market activity. Such commitments by major regional funds often signal confidence in specific investment avenues and contribute to the overall financial landscape's dynamism, providing a strong signal to both local and international investors.

Company Outlook

Deliberations regarding the potential public offering for Apex Health are currently ongoing, according to sources familiar with the matter. These sources indicated that Estithmar Holding QPSC has not yet reached any final decisions concerning either the specific timing or the ultimate size of any prospective deal. The company continues to evaluate its options for the healthcare subsidiary, with no definitive path forward publicly announced at this stage, emphasizing a careful and considered approach to this significant corporate action.

Estithmar's Strategic Vision

Apex Health, the healthcare subsidiary of Estithmar Holding QPSC, reported a strong profit of 592 million riyals ($162 million) in 2025. This strong financial performance underpins the strategic considerations for a potential listing of the unit, showcasing its profitability and growth potential to prospective investors. The proposed initial public offering (IPO) aligns with Estithmar Holding's broader vision for its diverse portfolio, aiming to unlock value for shareholders and potentially fund further expansion within the rapidly growing healthcare sector. The company's engagement of Rothschild & Co. As an advisor for the potential listing in Doha further shows the strategic importance and professional approach being taken for this key initiative.